{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:39:03Z","timestamp":1778625543751,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.trim.2023.101962","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:28:51Z","timestamp":1700760531000},"page":"101962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Examining the impact of immunosuppressive drugs on antibody-dependent cellular cytotoxicity (ADCC) of human peripheral blood natural killer (NK) cells and gamma delta (\u03b3\u03b4) T cells"],"prefix":"10.1016","volume":"82","author":[{"given":"Sedigheh","family":"Jalali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanda","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen P.","family":"Westall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"Reading","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy C.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.trim.2023.101962_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.6061\/clinics\/2014(Sup01)11","article-title":"Issues in solid-organ transplantation in children: translational research from bench to bedside","volume":"69","author":"Lipshultz","year":"2014","journal-title":"Clinics (Sao Paulo)"},{"issue":"20","key":"10.1016\/j.trim.2023.101962_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21(st) century","volume":"6","author":"Black","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"6","key":"10.1016\/j.trim.2023.101962_bb0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014985","article-title":"Why is organ transplantation clinically important?","volume":"3","author":"Grinyo","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"26","key":"10.1016\/j.trim.2023.101962_bb0020","first-page":"2580","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Lefaucheur","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.trim.2023.101962_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2005.00376.x","article-title":"Chronic renal allograft rejection: pathophysiologic considerations","volume":"68","author":"Joosten","year":"2005","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.trim.2023.101962_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(01)00119-4","article-title":"Chronic rejection","volume":"14","author":"Libby","year":"2001","journal-title":"Immunity."},{"key":"10.1016\/j.trim.2023.101962_bb0035","doi-asserted-by":"crossref","first-page":"7903471","DOI":"10.1155\/2017\/7903471","article-title":"Not all antibodies are created equal: factors that influence antibody mediated rejection","volume":"2017","author":"Butler","year":"2017","journal-title":"J Immunol Res"},{"issue":"8","key":"10.1016\/j.trim.2023.101962_bb0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1164\/rccm.200501-098WS","article-title":"Lung transplantation: opportunities for research and clinical advancement","volume":"172","author":"Wilkes","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.trim.2023.101962_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J. Heart Lung Transplant."},{"issue":"10","key":"10.1016\/j.trim.2023.101962_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205107","article-title":"The common rejection module in chronic rejection post lung transplantation","volume":"13","author":"Sacreas","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2023.101962_bb0055","series-title":"Lung Transplant Rejection","author":"Mrad","year":"2022"},{"issue":"12","key":"10.1016\/j.trim.2023.101962_bb0060","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2023.101962_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.immunol.15.1.203","article-title":"Fc receptor biology","volume":"15","author":"Daeron","year":"1997","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.trim.2023.101962_bb0070","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of fc\u2013Fc\u03b3R interactions in IgG-mediated microbial neutralization","volume":"212","author":"Stylianos Bournazos","year":"2015","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.trim.2023.101962_bb0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2015.02.004","article-title":"The perfect storm: HLA antibodies, complement, FcgammaRs, and endothelium in transplant rejection","volume":"21","author":"Thomas","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.trim.2023.101962_bb0080","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.trim.2023.101962_bb0085","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad Spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity."},{"issue":"6","key":"10.1016\/j.trim.2023.101962_bb0090","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1084\/jem.162.6.2089","article-title":"Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express fc receptors for IgG (CD16\/Leu-11 antigen)","volume":"162","author":"Lanier","year":"1985","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.trim.2023.101962_bb0095","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.4049\/jimmunol.136.12.4480","article-title":"The relationship of CD16 (Leu-11) and Leu-19 (NKH\u22121) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes","volume":"136","author":"Lanier","year":"1986","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.trim.2023.101962_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1078","article-title":"The complex existence of gammadelta T cells following transplantation: the good, the bad and the simply confusing","volume":"8","author":"Sullivan","year":"2019","journal-title":"Clin. Transl. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2023.101962_bb0105","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1097\/TP.0000000000002336","article-title":"Gammadelta T cells in transplantation: friend and foe","volume":"102","author":"Sullivan","year":"2018","journal-title":"Transplantation."},{"issue":"1","key":"10.1016\/j.trim.2023.101962_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0008-8749(92)90008-D","article-title":"CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypes","volume":"143","author":"Braakman","year":"1992","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.trim.2023.101962_bb0115","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2004-01-0331","article-title":"FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways","volume":"104","author":"Angelini","year":"2004","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.trim.2023.101962_bb0120","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.4049\/jimmunol.181.6.4219","article-title":"Elevated numbers of fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection","volume":"181","author":"Bjorkstrom","year":"2008","journal-title":"J. Immunol."},{"issue":"6013","key":"10.1016\/j.trim.2023.101962_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.trim.2023.101962_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOT.0b013e32834254cf","article-title":"Natural killer cells in rejection and tolerance of solid organ allografts","volume":"16","author":"Benichou","year":"2011","journal-title":"Curr. Opin. Organ Transplant."},{"issue":"2\u20133","key":"10.1016\/j.trim.2023.101962_bb0135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12026-014-8493-4","article-title":"NK cells after transplantation: friend or foe","volume":"58","author":"Hadad","year":"2014","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.trim.2023.101962_bb0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/cdd.2009.161","article-title":"Granzymes and perforin in solid organ transplant rejection","volume":"17","author":"Choy","year":"2010","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.trim.2023.101962_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/thoraxjnl-2018-212345","article-title":"Natural killer cells in lung transplantation","volume":"74","author":"Calabrese","year":"2019","journal-title":"Thorax."},{"key":"10.1016\/j.trim.2023.101962_bb0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2016.00251","article-title":"Recognition and regulation of T cells by NK cells","volume":"7","author":"Pallmer","year":"2016","journal-title":"Front. Immunol."},{"issue":"6424","key":"10.1016\/j.trim.2023.101962_bb0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.aat0066","article-title":"Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation","volume":"363","author":"Martins","year":"2019","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.trim.2023.101962_bb0160","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.21037\/jtd.2018.05.204","article-title":"Infections after lung transplantation","volume":"10","author":"Nosotti","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.trim.2023.101962_bb0165","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3389\/fimmu.2019.01997","article-title":"Improved overall survival, relapse-free-survival, and less graft-vs.-host-disease in patients with high immune reconstitution of TCR gamma delta cells 2 months after allogeneic stem cell transplantation","volume":"10","author":"Minculescu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2023.101962_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720966980","article-title":"The roles of gammadelta T cells in hematopoietic stem cell transplantation","volume":"29","author":"Ye","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.trim.2023.101962_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2015.00003","article-title":"Direct and indirect effects of cytomegalovirus-induced gammadelta T cells after kidney transplantation","volume":"6","author":"Couzi","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2023.101962_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060144","article-title":"Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition","volume":"8","author":"Meehan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2023.101962_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fimmu.2019.00556","article-title":"Small-molecule immunosuppressive drugs and therapeutic immunoglobulins differentially inhibit NK cell effector functions in vitro","volume":"10","author":"Pradier","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.trim.2023.101962_bb0190","first-page":"1039","article-title":"Immunosuppression in lung transplantation","volume":"6","author":"Scheffert","year":"2014","journal-title":"J. Thorac. Dis."},{"issue":"12","key":"10.1016\/j.trim.2023.101962_bb0195","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.21037\/jtd.2017.11.85","article-title":"Prevention of chronic rejection after lung transplantation","volume":"9","author":"Van Herck","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.trim.2023.101962_bb0200","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/527397","article-title":"Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences","volume":"46","author":"Legendre","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.trim.2023.101962_bb0205","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/TP.0000000000002335","article-title":"Deciphering the contribution of gammadelta T cells to outcomes in transplantation","volume":"102","author":"McCallion","year":"2018","journal-title":"Transplantation."},{"issue":"11","key":"10.1016\/j.trim.2023.101962_bb0210","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2013101052","article-title":"Cytomegalovirus-responsive gammadelta T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions","volume":"25","author":"Bachelet","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.trim.2023.101962_bb0215","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1182\/blood-2011-06-363655","article-title":"Antibody-dependent anti-cytomegalovirus activity of human gammadelta T cells expressing CD16 (FcgammaRIIIa)","volume":"119","author":"Couzi","year":"2012","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.trim.2023.101962_bb0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1084\/jem.20152023","article-title":"Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition","volume":"213","author":"Saunders","year":"2016","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.trim.2023.101962_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cellimm.2008.08.007","article-title":"Relationship between CD107a expression and cytotoxic activity","volume":"254","author":"Aktas","year":"2009","journal-title":"Cell. Immunol."},{"issue":"18","key":"10.1016\/j.trim.2023.101962_bb0230","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2012-04-425397","article-title":"NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)","volume":"121","author":"Romee","year":"2013","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.trim.2023.101962_bb0235","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: a prospective trial","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2023.101962_bb0240","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2023.101962_bb0245","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.180.8.5327","article-title":"Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity","volume":"180","author":"Clemenceau","year":"2008","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.trim.2023.101962_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008997","article-title":"Opsonized antigen activates Vdelta2+ T cells via CD16\/FCgammaRIIIa in individuals with chronic malaria exposure","volume":"16","author":"Farrington","year":"2020","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.trim.2023.101962_bb0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clim.2008.03.513","article-title":"CD16+ gammadelta T cells mediate antibody dependent cellular cytotoxicity: potential mechanism in the pathogenesis of multiple sclerosis","volume":"128","author":"Chen","year":"2008","journal-title":"Clin. Immunol."},{"issue":"25","key":"10.1016\/j.trim.2023.101962_bb0260","doi-asserted-by":"crossref","first-page":"19282","DOI":"10.1074\/jbc.M910487199","article-title":"Tumor necrosis factor-alpha production is differently regulated in gamma delta and alpha beta human T lymphocytes","volume":"275","author":"Lafont","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.trim.2023.101962_bb0265","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.4049\/jimmunol.166.12.7190","article-title":"Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of fc gamma RIIIA, the low affinity type 3 receptor for the fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen","volume":"166","author":"Lafont","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2023.101962_bb0270","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2006-10-048173","article-title":"The unexpected effect of cyclosporin a on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations","volume":"110","author":"Wang","year":"2007","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.trim.2023.101962_bb0275","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1189\/jlb.0310148","article-title":"FK506 causes cellular and functional defects in human natural killer cells","volume":"88","author":"Kim","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.trim.2023.101962_bb0280","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/j.1600-6143.2010.03242.x","article-title":"Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype","volume":"10","author":"Eissens","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2023.101962_bb0285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of gammadelta T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2023.101962_bb0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.trim.2019.02.005","article-title":"Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection","volume":"54","author":"Sablik","year":"2019","journal-title":"Transpl. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2023.101962_bb0295","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","article-title":"Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation","volume":"95","author":"Yazdani","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2023.101962_bb0300","article-title":"Diagnostic biomarkers and immune infiltration in patients with T cell-mediated rejection after kidney transplantation","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2023.101962_bb0305","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/TP.0000000000001586","article-title":"Evidence for CD16a-mediated NK cell stimulation in antibody-mediated kidney transplant rejection","volume":"101","author":"Parkes","year":"2017","journal-title":"Transplantation."},{"issue":"126","key":"10.1016\/j.trim.2023.101962_bb0310","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1183\/09059180.00006312","article-title":"Update on lung transplantation: programmes, patients and prospects","volume":"21","author":"Kotsimbos","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.trim.2023.101962_bb0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1183\/20734735.001913","article-title":"An update on lung transplantation","volume":"9","author":"Julia Fuller","year":"2013","journal-title":"Breathe"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742300179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742300179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:03:59Z","timestamp":1760810639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632742300179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":63,"alternative-id":["S096632742300179X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101962","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the impact of immunosuppressive drugs on antibody-dependent cellular cytotoxicity (ADCC) of human peripheral blood natural killer (NK) cells and gamma delta (\u03b3\u03b4) T cells","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101962"}}